They sure did, and that's exactly the point. Thacker Pass is projected to require CAPEX of US$2.93 billion. Financing has been secured from various channels, comprising: US$650 million from GM in exchange for exclusive offtake rights for the initial 15 years, a US$2.26 billion loan from the US Department of Energy (as previously mentioned by you), and the cap raise this week (US$275m), totalling US$3.185 billion. So even with US$2.91b of external funding already sorted (which is over 95% of projected CAPEX), LAC still had to dilute their existing shareholders by 25%, and at a 25% discount to boot.
Now, returning to my original (but connected) point. It's highly improbable for a strategic partner to invest funds equivalent to 2-3 times the market cap of a company, which is the likely requirement for AGY. The US Government isn't inclined to extend such a loan to AGY; the loan for Thacker Pass was earmarked for a strategic asset. Similarly, the Argentinian Government isn't poised to provide funding (because they're broke), nor is the Australian government solely because AGY is an Australian company. That really only leaves a pre-paid offtake, which has never occurred at the scale required by AGY (240% of market cap), handing over part ownership to someone else (which is just shareholder dilution in disguise) or non-government debt (which again is unlikely to cover 240% of market cap).
The most viable option entails leveraging a blend of financing sources, akin to what LAC did, including a cap raise. In the case of AGY I'm anticipating substantial dilution and a significant discount due to the current state of the lithium market.
- Forums
- ASX - By Stock
- AGY
- Ann: Rincon Lithium Project - Progress Update
AGY
argosy minerals limited
Add to My Watchlist
46.7%
!
2.2¢

Ann: Rincon Lithium Project - Progress Update, page-103
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.2¢ |
Change
0.007(46.7%) |
Mkt cap ! $32.03M |
Open | High | Low | Value | Volume |
1.6¢ | 2.3¢ | 1.6¢ | $650.0K | 32.46M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 2244584 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 657657 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 2244584 | 0.021 |
15 | 4785758 | 0.020 |
7 | 1552777 | 0.019 |
13 | 2630000 | 0.018 |
5 | 2465000 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 616218 | 5 |
0.023 | 1726058 | 10 |
0.024 | 4351568 | 15 |
0.025 | 1644007 | 7 |
0.026 | 330134 | 3 |
Last trade - 10.57am 27/06/2025 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online